FDA has fifty years of experience talking to drug sponsors about safety, efficacy and regulatory obligations. With that experience comes a specific language and de facto code of etiquette. The Food & Drug Administration and sponsors know what the agency can require, what it can't and the code words for signaling different attitudes that may not always be spelled out in regulations.
Now that Congress has assigned FDA the task of setting up a full-blown active surveillance network to track drugs and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?